GENSCRIPT
LIVE

Serial Number

79261866

Owner

Nanjing Genscript Biotech Co., Ltd

Attorney

Yue (Robert) Xu

Filing Date

Jan 4, 2019

Add to watchlist:

No watchlists yet
View on USPTO

GENSCRIPT Trademark

Serial Number: 79261866 • Registration: 6132435

GENSCRIPT is a trademark filed by Nanjing Genscript Biotech Co., Ltd on January 4, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

Nanjing Genscript Biotech Co., Ltd (36 trademarks)

No.28 Yongxi Road, Jiangning Science Park,

Entity Type: 99

Nanjingjinsirui Science & Technology Biology Corp. (11 trademarks)

Jiangning Science Park
Nanjing, Jiangsu 211100 , CN

Entity Type: 03

Trademark Details

Filing Date

January 4, 2019

Registration Date

August 25, 2020

Published for Opposition

June 9, 2020

Goods & Services

Recorded and downloadable computer application software for mobile phones, namely, software for use in database management and electronic storage of data; scientific instruments, namely, magnetic separation racks that use magnetic beads and particles to purify, isolate, and separate biological molecules; computer-controlled apparatus for testing and measuring magnetic beads, not for medical purposes; diagnostic apparatus that uses magnetic beads and particles to purify, isolate, and separate biological molecules, for laboratory or research use; DNA chips; surveying instruments; bioreactors for laboratory use; chromatography apparatus for laboratory use; magnetic separators for scientific use

Cultures of microorganisms for medical or veterinary use; bacterial preparations for medical and veterinary use; chemical reagents for medical or veterinary purposes; diastase for medical purposes; enzyme preparations for medical purposes; diagnostic preparations for medical purposes; nutraceuticals for use as a dietary supplement; pharmaceutical preparations for the treatment of multiple myeloma, blood cancer and solid tumor; chemical preparations for pharmaceutical or medical purposes, namely, for treating multiple myeloma, blood cancer and solid tumor; enzyme dietary supplements; enzyme preparations for veterinary purposes; biological preparations for the treatment of multiple myeloma, blood tumor and solid tumor

Enzyme preparations for use in the food, animal feeds and brewing industry; enzymes for industrial purposes; protein in raw material form for scientific and medical research; chemicals for use in industry; biochemical catalysts; diagnostic preparations other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; bacterial preparations, other than for medical and veterinary use; cultures of microorganisms other than for medical or veterinary use; electrophoresis gels other than for medical or veterinary purposes; enzymes for use in the food industry; enzymes for the brewing industry; proteins for the food industry; vitamins for manufacturing use

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 25, 2025 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 29, 2024 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 13, 2021 FINO
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 2, 2021 ADCH
GENERIC MADRID TRANSACTION SENT TO IB
Dec 16, 2020 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 15, 2020 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 25, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 25, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 9, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jun 5, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 20, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 20, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 11, 2020 GNRN
NON-FINAL ACTION E-MAILED
Mar 11, 2020 GNRT
NON-FINAL ACTION WRITTEN
Mar 11, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2020 CRFA
ASSIGNED TO LIE
Feb 18, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 12, 2020 TROA
REFUSAL PROCESSED BY IB
Aug 30, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 12, 2019 RFCS
REFUSAL PROCESSED BY MPU
Aug 12, 2019 RFRR
APPLICATION FILING RECEIPT MAILED
Jul 23, 2019 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 20, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jul 19, 2019 CNRT
ASSIGNED TO EXAMINER
Jul 19, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 19, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 12, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 27, 2019 REPR